BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 14755772)

  • 1. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS OPTN waiting list: 1988 to 1994. United Network for Organ Sharing. Organ Procurement and Transplantation Network.
    Guo TJ; Daily OP; Davies DB
    Clin Transpl; 1994; ():69-86. PubMed ID: 7547588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy.
    Freeman RB; Edwards EB
    Liver Transpl; 2000 Sep; 6(5):543-52. PubMed ID: 10980052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
    Freeman RB; Rohrer RJ; Katz E; Lewis WD; Jenkins R; Cosimi AB; Delmonico F; Friedman A; Lorber M; O'Connor K; Bradley J
    Liver Transpl; 2001 Mar; 7(3):173-8. PubMed ID: 11244156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UNOS OPTN waiting list: 1988-1995.
    Harper AM; Baker AS
    Clin Transpl; 1995; ():69-84. PubMed ID: 8794255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNOS OPTN (Organ Procurement and Transplantation Network) waiting list: 1988 through November 30, 1992.
    Edwards EB; Breen TJ; Guo T; Ellison MD; Daily OP
    Clin Transpl; 1992; ():61-75. PubMed ID: 1306723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new liver allocation system: moving toward evidence-based transplantation policy.
    Freeman RB; Wiesner RH; Harper A; McDiarmid SV; Lake J; Edwards E; Merion R; Wolfe R; Turcotte J; Teperman L;
    Liver Transpl; 2002 Sep; 8(9):851-8. PubMed ID: 12200791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent liver transplant survival rates under the MELD/PELD system.
    Freeman RB; Harper A; Edwards EB
    Transplant Proc; 2005 Mar; 37(2):585-8. PubMed ID: 15848465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
    Humar A; Khwaja K; Glessing B; Larson E; Asolati M; Durand B; Lake J; Payne WD
    Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.